Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-199,022
Closed -$19.1M 1696
2022
Q2
$19.1M Buy
199,022
+177,515
+825% +$21.3M 0.16% 92
2022
Q1
$3.19M Sell
21,507
-12,445
-37% -$1.74M 0.02% 528
2021
Q4
$4.81M Sell
33,952
-30,567
-47% -$4.33M 0.03% 471
2021
Q3
$8.44M Sell
64,519
-59,780
-48% -$7.82M 0.06% 307
2021
Q2
$17.1M Buy
124,299
+78,870
+174% +$10.8M 0.11% 152
2021
Q1
$5.93M Sell
45,429
-32,510
-42% -$3.91M 0.05% 326
2020
Q4
$8.73M Buy
77,939
+39,579
+103% +$3.75M 0.07% 250
2020
Q3
$3.02M Buy
+38,360
New +$3.13M 0.03% 424
2020
Q2
Sell
-4,565
Closed -$261K 1422
2020
Q1
$261K Buy
+4,565
New +$421K ﹤0.01% 1572
2019
Q2
Sell
-32,000
Closed -$2.66M 2569
2019
Q1
$2.66M Buy
+32,000
New +$2.33M 0.02% 754
2018
Q4
Sell
-3,733
Closed -$296K 2202
2018
Q3
$296K Sell
3,733
-3,564
-49% -$276K ﹤0.01% 1884
2018
Q2
$534K Sell
7,297
-4,793
-40% -$326K ﹤0.01% 1552
2018
Q1
$766K Buy
12,090
+8,169
+208% +$488K ﹤0.01% 1308
2017
Q4
$200K Buy
+3,921
New +$204K ﹤0.01% 2218
2015
Q3
Sell
-2,126
Closed -$124K 2383
2015
Q2
$124K Buy
+2,126
New +$115K ﹤0.01% 2124

Other funds holding CNMD

Jefferies Group's CNMD Position: Q3 2022 in Review

Jefferies Group sold out of CONMED (CNMD) in Q3 2022, closing a stake of 199,022 shares — an estimated $19.1M sold.

Jefferies Group first reported a position in CNMD in Q2 2015 and held it in 15 quarters. The position peaked at $19.1M in Q2 2022. 252 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

  • Jefferies Group reported no remaining CONMED position as of Q3 2022 after selling out during the quarter.
  • Jefferies Group sold 199,022 CONMED shares in Q3 2022, an estimated $19.1M.
  • Jefferies Group first reported a position in CONMED in Q2 2015 and held it in 15 quarters.
  • Jefferies Group's CONMED position peaked at $19.1M in Q2 2022.
  • 252 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.